MEDIZONE INTERNATIONAL INC AQUIRES PATENT NEW YORK MARCH 12  MEDIZONE INTERNATIONAL INC SAID IT ACQUIRED A PATENT THAT COVERS PROCEDURES FOR THE USE OF THE MEDIZONE THERAPY IN DEACTIVATING CERTAIN VIRUSES COMMONLY ASSOCIATED WITH AIDS HEPATITIS AND HERPES THE COMPANY SAID THE PATENT COVERS PROCEDURES FOR THE DEACTIVATION OF THE VIRUSES IN HUMAN AND ANIMAL BLOOD AND THE TREATMENT OF STORED BLOOD PRIOR TO TRANSFUSION MEDIZONE SAID THE ACQUISITION IS SEEN AS A SIGNIFICANT STEP TO ENHANCE THE COMPANY'S PROPRIETORY POSITION THE COMPANY SAID THE PATENT WAS ACQUIRED FROM AN UNNAMED COMPANY INVOLVED IN MEDICAL RESEARCH AND DEVELOPMENT FOR ONE MILLION SHARES OF ITS COMMON STOCK  